Gilead Sciences

Gilead Sciences

Campaigns

Corporate Social Responsibility
吉利德科技公司orate Social Responsibility
Age Positively
Those who experienced the early days of the HIV/AIDS epidemic remember the generation we lost and the enduring impact that has had on our community. Since then, we’ve made tremendous progress. This is the first time in American history when nearly 50% of people living with HIV are over...

Videos

Living with Metastatic Bladder Cancer: Joey's Journey
Living with Metastatic Bladder Cancer: Joey's Journey
Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies
Gilead Sciences Presents at ECCMID 2022 - Continues Mission to Advance Access to Effective Therapies
On Earth Day, Gilead Marks Strides in Environmental Sustainability
On Earth Day, Gilead Marks Strides in Environmental Sustainability
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
Mom Celebrates Sons' Milestones: Julie's CAR T-cell Therapy Journey
Channeling Her Passion to Spread Awareness About TNBC: LaToya's Journey
Channeling Her Passion to Spread Awareness About TNBC: LaToya's Journey
Opinion: Searching for the Next Generation of Sustainable Health Care
Opinion: Searching for the Next Generation of Sustainable Health Care
What World Cancer Day Means to Me
What World Cancer Day Means to Me
Living Well With Hepatitis B: Lai's Journey
Living Well With Hepatitis B: Lai's Journey
Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences
Inside the Innovation: Pharmaceutical Development and Manufacturing Leaders Share Experiences
Gilead's Rohini Mehtani, Ph.D. Reflects on The Importance of ASH21
Gilead's Rohini Mehtani, Ph.D. Reflects on The Importance of ASH21
Saying 'Not Today' to Triple-Negative Breast Cancer: Lee Ann's Journey
Saying 'Not Today' to Triple-Negative Breast Cancer: Lee Ann's Journey
Gildead Sciences Is Proud to Be a Presenting Partner of National AIDS Memorial's World AIDS Day: December 1, 2021
Gildead Sciences Is Proud to Be a Presenting Partner of National AIDS Memorial's World AIDS Day: December 1, 2021
'Inside the Innovation:' Oncology Leaders Discuss Life at Gilead
'Inside the Innovation:' Oncology Leaders Discuss Life at Gilead
Putting Faith Into Conversations About HIV in the Southern United States
Putting Faith Into Conversations About HIV in the Southern United States
Wake Forest University School of Divinity Brings Faith to the Gilead COMPASS Initiative®
Wake Forest University School of Divinity Brings Faith to the Gilead COMPASS Initiative®
Gilead Sciences: Committed to Addressing Barriers That Prohibit Care for Asian American and Native Hawaiian and Pacific Islander Populations
Gilead Sciences: Committed to Addressing Barriers That Prohibit Care for Asian American and Native Hawaiian and Pacific Islander Populations
A Workplace for Tomorrow
A Workplace for Tomorrow
Gilead Presents: Episode 5 - Assuring Possible
Gilead Presents: Episode 5 - Assuring Possible
Gilead and Kite Present: Episode 4 - Delivering Possible
Gilead and Kite Present: Episode 4 - Delivering Possible
Gilead Presents: Episode 3 - Championing Possible
Gilead Presents: Episode 3 - Championing Possible
Gilead Presents: Episode 2 - Realizing Possible
Gilead Presents: Episode 2 - Realizing Possible
Gilead Presents: Episode 1 - Defining Possible
Gilead Presents: Episode 1 - Defining Possible
Gilead and the Morehouse School of Medicine Partner to Study Racial Health Inequities Associated with COVID-19
Gilead and the Morehouse School of Medicine Partner to Study Racial Health Inequities Associated with COVID-19
Minimizing Gilead's Environmental Impact
Minimizing Gilead's Environmental Impact
Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan
Mastercard and Gilead Partner to Simplify Delivery of Hepatitis Treatment in Pakistan
Gilead Publishes 2017 Year in Review
Gilead Publishes 2017 Year in Review
Gilead Publishes 2017 Year in Review
Gilead Publishes 2017 Year in Review
Gilead Publishes 2017 Year in Review
Gilead Publishes 2017 Year in Review
基安ounces 10-Year, $100 Million Commitment to Address the HIV/AIDS Epidemic in the Southern United States
基安ounces 10-Year, $100 Million Commitment to Address the HIV/AIDS Epidemic in the Southern United States
Gilead Publishes Year in Review 2016
Gilead Publishes Year in Review 2016
Gilead Publishes Year in Review 2016
Gilead Publishes Year in Review 2016
Gilead Publishes Year in Review 2016
Gilead Publishes Year in Review 2016

Gilead Sciences ON SOCIAL MEDIA

Subscribe to Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.